187 related articles for article (PubMed ID: 29843121)
1. Alterations of Cortisol Metabolism in Human Disorders.
White PC
Horm Res Paediatr; 2018; 89(5):320-330. PubMed ID: 29843121
[TBL] [Abstract][Full Text] [Related]
2. Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action.
Stewart PM
Eur J Endocrinol; 2003 Sep; 149(3):163-8. PubMed ID: 12943516
[TBL] [Abstract][Full Text] [Related]
3. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
Whorwood CB; Stewart PM
J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency.
Draper N; Walker EA; Bujalska IJ; Tomlinson JW; Chalder SM; Arlt W; Lavery GG; Bedendo O; Ray DW; Laing I; Malunowicz E; White PC; Hewison M; Mason PJ; Connell JM; Shackleton CH; Stewart PM
Nat Genet; 2003 Aug; 34(4):434-9. PubMed ID: 12858176
[TBL] [Abstract][Full Text] [Related]
5. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action.
Draper N; Stewart PM
J Endocrinol; 2005 Aug; 186(2):251-71. PubMed ID: 16079253
[TBL] [Abstract][Full Text] [Related]
6. Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1.
Bujalska IJ; Draper N; Michailidou Z; Tomlinson JW; White PC; Chapman KE; Walker EA; Stewart PM
J Mol Endocrinol; 2005 Jun; 34(3):675-84. PubMed ID: 15956339
[TBL] [Abstract][Full Text] [Related]
7. Hexose-6-phosphate dehydrogenase and 11beta-hydroxysteroid dehydrogenase-1 tissue distribution in the rat.
Gomez-Sanchez EP; Romero DG; de Rodriguez AF; Warden MP; Krozowski Z; Gomez-Sanchez CE
Endocrinology; 2008 Feb; 149(2):525-33. PubMed ID: 18039793
[TBL] [Abstract][Full Text] [Related]
8. Relationship of 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase gene polymorphisms with metabolic syndrome and type 2 diabetes.
Moon SS; Lee YS; Kim JG; Kim SW; Jeong JY; Jeon EJ; Seo HA; Kwak SH; Park KS; Lee IK
Endocr J; 2011; 58(11):949-59. PubMed ID: 21869537
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.
Stewart PM; Toogood AA; Tomlinson JW
Horm Res; 2001; 56 Suppl 1():1-6. PubMed ID: 11786677
[TBL] [Abstract][Full Text] [Related]
10. Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.
Tomlinson JW; Stewart PM
Best Pract Res Clin Endocrinol Metab; 2001 Mar; 15(1):61-78. PubMed ID: 11469811
[TBL] [Abstract][Full Text] [Related]
11. The role of 11 beta-hydroxysteroid dehydrogenase in the pathogenesis of hypertension.
van Uum SH; Hermus AR; Smits P; Thien T; Lenders JW
Cardiovasc Res; 1998 Apr; 38(1):16-24. PubMed ID: 9683905
[TBL] [Abstract][Full Text] [Related]
12. 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action.
Seckl JR
Curr Opin Pharmacol; 2004 Dec; 4(6):597-602. PubMed ID: 15525550
[TBL] [Abstract][Full Text] [Related]
13. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH
J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847
[TBL] [Abstract][Full Text] [Related]
14. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes.
Jang C; Obeyesekere VR; Dilley RJ; Krozowski Z; Inder WJ; Alford FP
J Clin Endocrinol Metab; 2007 Aug; 92(8):3314-20. PubMed ID: 17519316
[TBL] [Abstract][Full Text] [Related]
15. Hexose-6-phosphate dehydrogenase modulates 11beta-hydroxysteroid dehydrogenase type 1-dependent metabolism of 7-keto- and 7beta-hydroxy-neurosteroids.
Nashev LG; Chandsawangbhuwana C; Balazs Z; Atanasov AG; Dick B; Frey FJ; Baker ME; Odermatt A
PLoS One; 2007 Jun; 2(6):e561. PubMed ID: 17593962
[TBL] [Abstract][Full Text] [Related]
16. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.
Tomlinson JW; Walker EA; Bujalska IJ; Draper N; Lavery GG; Cooper MS; Hewison M; Stewart PM
Endocr Rev; 2004 Oct; 25(5):831-66. PubMed ID: 15466942
[TBL] [Abstract][Full Text] [Related]
17. Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol.
Morris DJ; Latif SA; Hardy MP; Brem AS
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):161-8. PubMed ID: 17459698
[TBL] [Abstract][Full Text] [Related]
18. Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency.
Lavery GG; Walker EA; Tiganescu A; Ride JP; Shackleton CH; Tomlinson JW; Connell JM; Ray DW; Biason-Lauber A; Malunowicz EM; Arlt W; Stewart PM
J Clin Endocrinol Metab; 2008 Oct; 93(10):3827-32. PubMed ID: 18628520
[TBL] [Abstract][Full Text] [Related]
19. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?
Palermo M; Delitala G; Sorba G; Cossu M; Satta R; Tedde R; Pala A; Shackleton CH
J Endocrinol Invest; 2000; 23(7):457-62. PubMed ID: 11005270
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of 11beta-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes.
Abdallah BM; Beck-Nielsen H; Gaster M
Eur J Clin Invest; 2005 Oct; 35(10):627-34. PubMed ID: 16178882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
